Year |
Citation |
Score |
2019 |
Han H, Jain AD, Truica MI, Izquierdo-Ferrer J, Anker JF, Lysy B, Sagar V, Luan Y, Chalmers ZR, Unno K, Mok H, Vatapalli R, Yoo YA, Rodriguez Y, Kandela I, et al. Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy. Cancer Cell. PMID 31679823 DOI: 10.1016/J.Ccell.2019.10.001 |
0.337 |
|
2018 |
Frankowski KJ, Wang C, Patnaik S, Schoenen FJ, Southall N, Li D, Teper Y, Sun W, Kandela I, Hu D, Dextras C, Knotts Z, Bian Y, Norton J, Titus S, et al. Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis. Science Translational Medicine. 10. PMID 29769289 DOI: 10.1126/Scitranslmed.Aap8307 |
0.305 |
|
2018 |
Kamoun W, Swindell E, Pien C, Luus L, Cain J, Kandela I, Huang R, Tipparaju S, Kirpotin D, Bshara W, Askoxylakis V, Morrison C, Drummond D. Abstract 5771: Targeting EphA2 in bladder cancer using a novel antibody-directed nanotherapeutic Cancer Research. 78: 5771-5771. DOI: 10.1158/1538-7445.Am2018-5771 |
0.363 |
|
2017 |
Liu Y, Lou G, Norton JT, Wang C, Kandela I, Tang S, Shank NI, Gupta P, Huang M, Avram MJ, Green R, Mazar A, Appella D, Chen Z, Huang S. 6-Methoxyethylamino-numonafide inhibits hepatocellular carcinoma xenograft growth as a single agent and in combination with sorafenib. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 28821631 DOI: 10.1096/Fj.201700306Rr |
0.301 |
|
2017 |
Kandela IK, McAuliffe KJ, Cochran LE, Barrett AGM, Hoffman BM, Mazar AP, Trivedi ER. Discovery of the Antitumor Effects of a Porphyrazine Diol (Pz 285) in MDA-MB-231 Breast Tumor Xenograft Models in Mice. Acs Medicinal Chemistry Letters. 8: 705-709. PMID 28740602 DOI: 10.1021/Acsmedchemlett.7B00063 |
0.322 |
|
2017 |
Aird F, Kandela I, Mantis C. Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Elife. 6. PMID 28100400 DOI: 10.7554/Elife.21253 |
0.306 |
|
2017 |
Kandela I, Aird F. Replication Study: Discovery and preclinical validation of drug indications using compendia of public gene expression data. Elife. 6. PMID 28100397 DOI: 10.7554/Elife.17044 |
0.303 |
|
2017 |
Mantis C, Kandela I, Aird F. Replication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Elife. 6. PMID 28100395 DOI: 10.7554/Elife.17584 |
0.316 |
|
2016 |
Hendrix MJ, Kandela I, Mazar AP, Seftor EA, Seftor RE, Margaryan NV, Strizzi L, Murphy GF, Long GV, Scolyer RA. Targeting melanoma with front-line therapy does not abrogate Nodal-expressing tumor cells. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 27775691 DOI: 10.1038/Labinvest.2016.107 |
0.337 |
|
2016 |
Ravi D, Beheshti A, Abermil N, Passero F, Sharma J, Coyle M, Kritharis A, Kandela I, Hlatky L, Sitkovsky MV, Mazar AP, Gartenhaus RB, Evens AM. Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC Dependent Cell Death in T-Cell and Hodgkin Lymphoma. Cancer Research. PMID 26988986 DOI: 10.1158/0008-5472.Can-15-2477 |
0.32 |
|
2016 |
Mantis C, Kandela I, Aird F. Author response: Replication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs Elife. DOI: 10.7554/Elife.17584.012 |
0.305 |
|
2015 |
Kandela I, Chou J, Chow K. Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Elife. 4. PMID 27879198 DOI: 10.7554/Elife.06959 |
0.329 |
|
2015 |
Kandela I, Jin HY, Owen K. Registered report: BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Elife. 4. PMID 26111384 DOI: 10.7554/Elife.07072 |
0.306 |
|
2015 |
Kandela I, Chou J, Chow K. Correction: Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Elife. 4. PMID 26052861 DOI: 10.7554/Elife.09169 |
0.307 |
|
2015 |
Swanson KI, Clark PA, Zhang RR, Kandela IK, Farhoud M, Weichert JP, Kuo JS. Fluorescent cancer-selective alkylphosphocholine analogs for intraoperative glioma detection. Neurosurgery. 76: 115-23; discussion 1. PMID 25549194 DOI: 10.1227/Neu.0000000000000622 |
0.347 |
|
2015 |
Dam DH, Culver KS, Kandela I, Lee RC, Chandra K, Lee H, Mantis C, Ugolkov A, Mazar AP, Odom TW. Biodistribution and in vivo toxicity of aptamer-loaded gold nanostars. Nanomedicine : Nanotechnology, Biology, and Medicine. 11: 671-9. PMID 25461281 DOI: 10.1016/J.Nano.2014.10.005 |
0.333 |
|
2015 |
Kandela I, Chou J, Chow K. Author response: Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs Elife. DOI: 10.7554/Elife.06959.003 |
0.305 |
|
2015 |
Wang C, Frankowski K, Yaroslav T, Patnaik S, Schoenen F, Southall N, Sun W, Titus S, Griner L, Dextras C, Sultan J, Kandela I, Lewandowska M, Wen Y, Norton J, et al. Abstract 5368: Metarrestin effectively disassembles PNCs and inhibits metastasis Cancer Research. 75: 5368-5368. DOI: 10.1158/1538-7445.Am2015-5368 |
0.327 |
|
2014 |
Ravi D, Bhalla S, Gartenhaus RB, Crombie J, Kandela I, Sharma J, Mazar A, Evens AM. The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6023-33. PMID 25316819 DOI: 10.1158/1078-0432.Ccr-14-1532 |
0.315 |
|
2014 |
Weichert JP, Clark PA, Kandela IK, Vaccaro AM, Clarke W, Longino MA, Pinchuk AN, Farhoud M, Swanson KI, Floberg JM, Grudzinski J, Titz B, Traynor AM, Chen HE, Hall LT, et al. Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy. Science Translational Medicine. 6: 240ra75. PMID 24920661 DOI: 10.1126/Scitranslmed.3007646 |
0.326 |
|
2014 |
Dashnamoorthy R, Behesti A, Abermil N, Sharma J, Coyle M, Kandela I, Mazar A, Hlatky L, Evens AM. Genome-Wide Analysis Reveals MYC-Dependent Cell Death and Identifies Predictive Biomarkers of Ixazomib Sensitivity in Preclinical Models of T-Cell Lymphoma (TCL) and Hodgkin Lymphoma (HL) Blood. 124: 3120-3120. DOI: 10.1182/Blood.V124.21.3120.3120 |
0.329 |
|
2014 |
Kuo JS, Weichert JP, Clark PA, Kandela IK, Vacaro A, Clark W, Longino M, Pinchuk A, Farhoud M, Swanson KI, Floberg J, Traynor A, Hall LT, Pazoles C. NOVEL ALKYLPHOSPHOCHOLINE ANALOGS FOR BROAD SPECTRUM CANCER IMAGING AND THERAPY Neuro-Oncology. 16: iii10-iii11. DOI: 10.1093/Neuonc/Nou206.37 |
0.363 |
|
2013 |
Dashnamoorthy R, Kandela I, Bhalla S, Mazar A. Evaluation Of Potency and The Associated Biology Of The Investigational Proteasome Inhibitor, Ixazomib: Redox, Autophagic, and MAPK-Dependent Cell Death In T-Cell Lymphoma (TCL) and Hodgkin Lymphoma (HL) Cell Lines and Human Lymphoma Xenograft Models Blood. 122: 4407-4407. DOI: 10.1182/Blood.V122.21.4407.4407 |
0.328 |
|
2013 |
Kandela I, Ugolkov A, Francia G, Rabbani S, Kerbel RS, Mazar AP. Abstract 863: Inhibition of breast cancer metastaticprogression by a novel uPAR targeted monoclonal antibody, ATN-658, correlateswith the uPAR expression. Cancer Research. 73: 863-863. DOI: 10.1158/1538-7445.Am2013-863 |
0.352 |
|
2012 |
Dashnamoorthy R, Kandela I, Bhalla S, Galloway J, Zaretsky I, Mazar A, Evens AM. The 2nd Generation Proteasome Inhibitor, MLN2238: Potent Induction of Cell Death in T-Cell Lymphoma (TCL) and Hodgkin Lymphoma (HL) Cell Lines and in Two Human Lymphoma Xenograft Models. Blood. 120: 2767-2767. DOI: 10.1182/Blood.V120.21.2767.2767 |
0.334 |
|
2012 |
Dashnamoorthy R, Bhalla S, Crombie J, Kandela I, Mazar A, Evens AM. Darinaparsin in T-Cell Lymphoma (TCL) and Hodgkin Lymphoma (HL) Cells Lines and SCID Xenograft Mouse Models: Single-Agent Activity and Synergistic Cell Death Combined with a PI3K/mTOR Inhibitor Blood. 120: 1646-1646. DOI: 10.1182/Blood.V120.21.1646.1646 |
0.324 |
|
2012 |
Pazoles C, Vaccaro A, Kandela I, Pinchuk A, Farhoud M, Longino M, Weichert J. Abstract 5740:124I-CLR1404 and131I-CLR1404: Broad spectrum diapeutic agents for cancer cell-targeted PET imaging and molecular radiotherapy Cancer Research. 72: 5740-5740. DOI: 10.1158/1538-7445.Am2012-5740 |
0.361 |
|
2012 |
Pazoles C, Vaccaro A, Kandela I, Pinchuk A, Farhoud M, Longino M, Weichert J. Abstract 3831: 131I-CLR1404 and CLR1404: Broad spectrum, cancer-targeted molecular radio- and chemotherapeutic phospholipid ether analogs Cancer Research. 72: 3831-3831. DOI: 10.1158/1538-7445.Am2012-3831 |
0.359 |
|
2012 |
Clark PA, Chen H, Mohamed M, Kandela IK, Longino MA, Pinchuk A, Weichert JP, Kuo JS. Abstract 3495: The novel phospholipid ether analog CLR1404 decreases glioblastoma stem cell proliferation, suppresses GBM growth, and improves survival Cancer Research. 72: 3495-3495. DOI: 10.1158/1538-7445.Am2012-3495 |
0.345 |
|
2008 |
Bleher R, Kandela I, Meyer DA, Albrecht RM. Immuno-EM using colloidal metal nanoparticles and electron spectroscopic imaging for co-localization at high spatial resolution. Journal of Microscopy. 230: 388-95. PMID 18503664 DOI: 10.1111/J.1365-2818.2008.01997.X |
0.59 |
|
2008 |
Kandela IK, Bleher R, Albrecht RM. Immunolabeling for correlative light and electron microscopy on ultrathin cryosections. Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada. 14: 159-65. PMID 18312726 DOI: 10.1017/S1431927608080239 |
0.593 |
|
2007 |
Kandela IK, Bleher R, Albrecht RM. Multiple correlative immunolabeling for light and electron microscopy using fluorophores and colloidal metal particles. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 55: 983-90. PMID 17652267 DOI: 10.1369/Jhc.6A7124.2007 |
0.608 |
|
2007 |
Kandela IK, Albrecht RM. Fluorescence quenching by colloidal heavy metals nanoparticles: implications for correlative fluorescence and electron microscopy studies. Scanning. 29: 152-61. PMID 17477396 DOI: 10.1002/Sca.20055 |
0.59 |
|
2007 |
Kaiser M, Heintz J, Kandela I, Albrecht R. Tumor Cell Death Induced by Membrane Melting via Immunotargeted, Inductively Heated Core/Shell Nanoparticles Microscopy and Microanalysis. 13. DOI: 10.1017/S1431927607073795 |
0.544 |
|
2006 |
Meyer DA, Bleher R, Kandela IK, Oliver JA, Albrecht RM. The development of alternative markers for transmission electron microscopy and correlative transmission electon and light microscopies Microscopy and Microanalysis. 12: 32-33. DOI: 10.1017/S1431927606069121 |
0.561 |
|
2004 |
Kandela IK, Bleher R, Albrecht RM. Correlative Labeling Studies in Light and Electron Microscopy Microscopy and Microanalysis. 10: 1212-1213. DOI: 10.1017/S1431927604884393 |
0.574 |
|
2003 |
Kandela I, Meyer D, Oshel P, Rosa-Molinar E, Albrecht RM. Fluorescence Quenching by Colloidal Heavy Metals: Implications for Correlative Fluorescence and Electron Microscopy Studies Microscopy and Microanalysis. 9: 1194-1195. DOI: 10.1017/S1431927603445972 |
0.58 |
|
2002 |
Kandela IK, Bartlett JA, Indig GL. Effect of molecular structure on the selective phototoxicity of triarylmethane dyes towards tumor cells. Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society For Photobiology. 1: 309-14. PMID 12653467 DOI: 10.1039/B110572H |
0.331 |
|
Show low-probability matches. |